Millennium Capital Advisors LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 4,063 shares of the company’s stock, valued at approximately $648,000. Millennium Capital Advisors LLC owned 0.12% of Direxion Daily S&P Biotech Bull 3x Shares at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Qube Research & Technologies Ltd acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at approximately $26,000. Headlands Technologies LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at approximately $69,000. Bank of America Corp DE increased its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 134.2% in the third quarter. Bank of America Corp DE now owns 2,476 shares of the company’s stock valued at $232,000 after purchasing an additional 1,419 shares during the period. Group One Trading LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at approximately $349,000. Finally, CIBC Private Wealth Group LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at approximately $351,000.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
NYSEARCA:LABU opened at $172.57 on Friday. The stock’s 50 day simple moving average is $173.84 and its 200-day simple moving average is $163.71. Direxion Daily S&P Biotech Bull 3x Shares has a 12-month low of $47.53 and a 12-month high of $212.45.
Direxion Daily S&P Biotech Bull 3x Shares Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
